European Association of Nuclear Medicine (EANM)’s Post

Wim Oyen, Chair of the EANM Policy & Regulatory Affairs Council (PRAC), recently discussed the pressing issue of isotope shortages in an interview with the Dutch broadcaster NOS.    During the interview, Wim highlighted Europe's significant reliance on Russia's nuclear industry for the production of certain radioactive drug treatments, particularly those used in prostate cancer therapy. These treatments depend on processed raw materials that are predominantly sourced from Russia, underscoring a critical vulnerability in Europe's healthcare supply chain.    Addressing this dependency is a key focus for the #EANM, which consistently advocates for the European Commission to implement measures aimed at reducing reliance on external sources.    🎤 Watch the interview (in Dutch): https://lnkd.in/dZJ2-fgf   📑 Read more (in Dutch): https://lnkd.in/ddB7ZDnx

NOS Journaal | NPO Start

NOS Journaal | NPO Start

npo.nl

To view or add a comment, sign in

Explore topics